bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Stock Short Interest Falls 85.9%

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 445 shares, a drop of 85.9% from the August 31st total of 3,162 shares. Based on an average daily trading volume, of 30,259 shares, the days-to-cover ratio is presently 0.0 days.

bioAffinity Technologies Price Performance

Shares of BIAFW traded down $0.04 during trading on Friday, reaching $0.28. 1,118 shares of the company traded hands, compared to its average volume of 5,427. bioAffinity Technologies has a twelve month low of $0.05 and a twelve month high of $0.98. The stock has a 50-day simple moving average of $0.20 and a 200-day simple moving average of $0.23.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc is a biotechnology company focused on developing diagnostic and therapeutic products for cancer and other serious diseases. The company’s platform uses proprietary porphyrin-based compounds designed to selectively interact with cancer cells and support their detection or treatment.

Its lead diagnostic product, CyPath Lung, is a noninvasive urine test intended to aid in the detection of lung cancer. The test uses a porphyrin compound delivered in nanoparticles and analyzed through fluorescence-based methods.